Alternative therapies for common dermatologic disorders, Part 1

Primary Care - Clinics in Office Practice

Volumn 37, Issue 2, 2010, Pages 269-283

  Morelli, Vincent ^a   Calmet, Erick ^a   Jhingade, Varalakshmi ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Alternative medicine; Apthous stomatitis; Dermatology; Herpes simplex; Psoriases; Rosacea; Seborrheic dermatitis; Urticaria

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; ASCORBIC ACID; ASCOXAL; AZELAIC ACID; CAPSAICIN; CHIBIXIAO RECIPE; CHRYSANTHELLUM INDICUM EXTRACT; FAMCICLOVIR; FOOD ADDITIVE; GLYCYRRHIZA GLABRA EXTRACT; KETOCONAZOLE; LITHIUM GLUCONATE; LYSINE; MELISSA OFFICINALIS EXTRACT; METRONIDAZOLE; NICKEL SULFATE; PLACEBO; PLANT EXTRACT; POTASSIUM BROMIDE; PYRIDOXINE; RHUBARB EXTRACT; SODIUM BROMIDE; SODIUM CHLORIDE; SUCCINATE LITHIUM; SUNSCREEN; TEA TREE OIL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALACICLOVIR; ZINC OXIDE; ZINC SULFATE;

ABSENCE OF SIDE EFFECTS; ALTERNATIVE MEDICINE; CHRONIC URTICARIA; CHRYSANTHELLUM INDICUM; CLINICAL TRIAL; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; GENITAL HERPES; HERPES LABIALIS; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; HYPNOSIS; LOW DRUG DOSE; MEDICINAL PLANT; PATIENT SATISFACTION; PLASMAPHERESIS; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RECURRENT INFECTION; RELAPSE; RELAXATION TRAINING; REVIEW; ROSACEA; SEBORRHEIC DERMATITIS; SINGLE DRUG DOSE; SKIN DISEASE; ULTRAVIOLET B RADIATION; UNSPECIFIED SIDE EFFECT;

COMPLEMENTARY THERAPIES; DERMATITIS, SEBORRHEIC; HERPES GENITALIS; HUMANS; NEURALGIA, POSTHERPETIC; PHYTOTHERAPY; RECURRENCE; ROSACEA; SKIN DISEASES; STOMATITIS, HERPETIC; URTICARIA;

EID: 77952919554     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2010.02.004     Document Type: Review

References (74)

1. Bamford J.T. Rosacea: current thoughts on origin. Semin Cutan Med Surg 2001, 20:199-206.
2. Blount B.W., Pelletier A.L. Rosacea: a common, yet commonly overlooked, condition. Am Fam Physician 2002, 66:435-440.
3. Bamford J.T., Tilden R.L., Blankush J.L., et al. Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol 1999, 135:659-663.
4. Roihu T., Kariniemi A.L. Demodex mites in acne rosacea. J Cutan Pathol 1998, 25:550-552.
5. Szlachcic A., Sliwowski Z., Karczewska E., et al. Helicobacter pylori and its eradication in rosacea. J Physiol Pharmacol 1999, 50:777-786.
6. Honore-Thorez D. J Pharm Belg 1985, 40(5):323-331. [in French].
7. Rigopoulos D., Kalogeromitros D., Gregoriou S., et al. Randomized placebo-controlled trial of a flavonoid-rich plant extract-based cream in the treatment of rosacea. J Eur Acad Dermatol Venereol 2005, 19(5):564-568.
8. Yu T.G., Zheng Y.Z., Zhu J.T., et al. Effect of treatment of rosacea in females by Chibixiao Recipe in combination with minocycline and spironolactone. Integr Med 2006, 12(4):277-280.
9. Bjerke R., Fyrand O., Graupe K. Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea. Acta Derm Venereol 1999, 79:456-459.
10. Maddin S. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol 1999, 40(6 Pt 1):961-965.
11. Pizzorno J.E., Murray M.T. Rosacea. Textbook of natural medicine 1999, vol. 2. 2nd edition:1538. Churchill Livingstone, New York. J.E. Pizzorno, M.T. Murray (Eds.).
12. D'Auria F.D., Laino L., Strippoli V., et al. In vitro activity of tea tree oil against Candida albicans mycelial conversion and other pathogenic fungi. J Chemother 2001, 13:377-383.
13. Satchell A.C., Saurajen A., Bell C., et al. Treatment of dandruff with 5% tea tree oil shampoo. J Am Acad Dermatol 2002, 47:852-855.
14. Efalith Multicenter Trial Group A double-blind, placebo-controlled, multicenter trial of lithium succinate ointment in the treatment of seborrheic dermatitis. J Am Acad Dermatol 1992, 26(3 Pt 2):452-457.
15. Dreno B., Moyse D. Lithium gluconate in the treatment of seborrhoeic dermatitis: a multicenter, randomised, double-blind study versus placebo. Eur J Dermatol 2002, 12:549-552.
16. Dreno B., Chosidow O., Revuz J., et al. Lithium gluconate 8% vs ketoconazole 2% in the treatment of seborrhoeic dermatitis: a multicentre, randomized study. Br J Dermatol 2003, 148:1230-1236.
17. Smith S.A., Baker A.E., Williams J.H. Effective treatment of seborrheic dermatitis using a low dose, oral homeopathic medication consisting of potassium bromide, sodium bromide, nickel sulfate, and sodium chloride in a double-blind, placebo-controlled study. Altern Med Rev 2002, 7(1):59-67.
18. Negro-Alvarez J.M., Miralles-Lopez J.C. Chronic idiopathic urticaria treatment. Allergol Immunopathol (Madr) 2001, 29:129-132.
19. Soter N.A. Acute and chronic urticaria and angioedema. J Am Acad Dermatol 1991, 25(1 Pt 2):146-154.
20. Burrall B.A., Halpern G.M., Huntley A.C. Chronic urticaria. West J Med 1990, 152:268-276.
21. Grattan C.E., Sabroe R.A., Greaves M.W. Chronic urticaria. J Am Acad Dermatol 2002, 46:645-657. [quiz: 657-60].
22. Greaves M.W. Pathophysiology of chronic urticaria. Int Arch Allergy Immunol 2002, 127:3-9.
23. Zuberbier T., Chantraine-Hess S., Hartmann K., et al. Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol 1995, 75:484-487.
24. Jiang X., Lu M., Ying Y., et al. A case report of double-filtration plasmapheresis for the resolution of refractory chronic urticaria. Ther Apher Dial 2008, 12(6):505-508.
25. Walters I.B., Ozawa M., Cardinale I., et al. Narrowband (312 nm) uv-B suppresses interferon gamma and interleukin (iL) 12 and increases iL-4 transcripts: differential regulation of cytokines at the single-cell level. Arch Dermatol 2003, 139:155-161.
26. Ibbotson S.H., Bilsland D., Cox N.H., et al. An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology group Workshop Report. Br J Dermatol 2004, 151:283-297.
27. Johnsson M., Falk E.S., Volden G. UVB treatment of factitious urticaria. Photodermatol 1987, 4:302-304.
28. Berroeta L., Clark C., Ibbotson S.H., et al. Narrow-band (TL-01) ultraviolet B phototherapy for chronic urticaria. Clin Exp Dermatol 2004, 29(1):97-98.
29. Engin B., Özdemir M., Balevi A., et al. Treatment of chronic urticaria with narrowband ultraviolet b phototherapy: a randomized controlled trial. Acta Derm Venereol 2008, 88:247-251.
30. Rudzki E., Czubalski K., Grzywa Z. Detection of urticaria with food additives intolerance by means of diet. Dermatologica 1980, 161:57-62.
31. Collins-Williams C. Clinical spectrum of adverse reactions to tartrazine. J Asthma 1985, 22:139-143.
32. Wright A.L., Minford A. Urticaria and hidden salicylates. Pediatr Dermatol 1999, 16:463-464.
33. Roberts-Thomson P.J., Chan A., Kupa A., et al. Urticaria and angio-oedema. Med J Aust 1984, 141(Suppl 5):S34-S37.
34. Shertzer C.L., Lookingbill D.P. Effects of relaxation therapy and hypnotizability in chronic urticaria. Arch Dermatol 1987, 123:913-916.
35. Xu F., Schillinger J.A., Sternberg M.R., et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J Infect Dis 2002, 185:1019-1024.
36. Corey L. Challenges in genital herpes simplex virus management. J Infect Dis 2002, 186(Suppl 1):S29-S33.
37. Oliver L., Wald A., Kim M., et al. Seroprevalence of herpes simplex virus infections in a family medicine clinic. Arch Fam Med 1995, 4:228-232.
38. Koutsky L.A., Ashley R.L., Holmes K.K., et al. The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sex Transm Dis 1990, 17:90-94.
39. Opstelten W., Neven A.K., Eekhof J. Treatment and prevention of herpes labialis. Can Fam Physician 2008, 54(12):1683-1687.
40. Amir J., Harel L., Smetana Z., et al. Treatment of herpes simplex gingivostomatitis with aciclovir in children: a randomised double blind placebo controlled study. BMJ 1997, 314(7097):1800-1803.
41. Spruance S.L., Bodsworth N., Resnick H., et al. Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis. J Am Acad Dermatol 2006, 55(1):47-53.
42. Spruance S.L., Jones T.M., Blatter M.M., et al. High dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo controlled, multicenter studies. Antimicrobial Agents Chemother 2003, 47(3):1072-1080.
43. Godfrey H.R., Godfrey N.J., Godfrey J.C., et al. A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine. Altern Ther Health Med 2001, 7:49-56.
44. Lin L., Chen X.S., Cui P.G., et al. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial. J Dermatolog Treat 2002, 13(2):67-72.
45. Femiano F., Gombos F., Scully C. Recurrent herpes labialis: a pilot study of the efficacy of zinc therapy. J Oral Pathol Med 2005, 34(7):423-425.
46. Hovi T., Hirvimies A., Stenvik M., et al. Topical treatment of recurrent mucocutaneous herpes with ascorbic acid-containing solution. Antiviral Res 1995, 27:263-270.
47. Saller R., Buechi S., Meyrat R., et al. Combined herbal preparation for topical treatment of Herpes labialis. Forsch Komplementarmed Klass Naturheilkd 2001, 8:373-382.
48. Spruance S.L., Rea T.L., Thoming C., et al. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group. JAMA 1997, 277:1374-1379.
49. Griffith R.S., Walsh D.E., Myrmel K.H., et al. Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Dermatologica 1987, 175:183-190.
50. McCune M.A., Perry H.O., Muller S.A., et al. Treatment of recurrent herpes simplex infections with L-lysine monohydrochloride. Cutis 1984, 34(4):366-373.
51. Simon C.A., Van Melle G.D., Ramelet A.A. Failure of lysine in frequently recurrent herpes simplex infection. Arch Dermatol 1985, 121:167-168.
52. DiGiovanna J.J., Blank H. Failure of lysine in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Arch Dermatol 1984, 120:48-51.
53. Milman N., Scheibel J., Jessen O. Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study. Acta Derm Venereol 1980, 60:85-87.
54. Dimitrova Z., Dimov B., Manolova N., et al. Antiherpes effect of Melissa officinalis L. extracts. Acta Microbiol Bulg 1993, 29:65-72.
55. Wolbling R.H., Leonhardt K. Local therapy of herpes simplex with dried extract from Melissa Officinalis. Phytomedicine 1994, 1:24-31.
56. Koytchev R., Alken R.G., Dundarov S. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis. Phytomedicine 1999, 6:225-230.
57. Pompei R., Flore O., Marccialis M.A., et al. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature 1979, 281:689-690.
58. Murray M.T., Pizzorno J.E. Herpes simplex. Alternative medicine: an objective assessment 2000, 1275. American Medical Association, Chicago (IL). P.B. Fontanarosa (Ed.).
59. Rooney J.F., Bryson Y., Mannix M.L., et al. Prevention of ultraviolet-light-induced herpes labialis by sunscreen. Lancet 1991, 338(8780):1419-1422.
60. Ness S.R., McCarty M.F. Does supplemental creatine prevent herpes recurrences?. Med Hypotheses 2001, 57:310-312.
61. Fife K.H., Warren T.J., Justus S.E., et al. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients. Sex Transm Dis 2008, 35(7):668-673.
62. Wald A., Carrell D., Remington M., et al. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection. Clin Infect Dis 2002, 34(7):944-948.
63. Bodsworth N., Bloch M., McNulty A., et al. 2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FAST study. Sex Health 2008, 5(3):219-225. [Erratum in: Sex Health. 2008 Dec;5(4):379].
64. Aoki F.Y., Tyring S., Diaz-Mitoma F., et al. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2006, 42(1):8-13. [Erratum in: Clin Infect Dis 2006;42(4):588].
65. Hijikata Y., Yamada S., Yasuhara A. Herbal mixtures containing the mushroom Ganoderma lucidum improve recovery time in patients with herpes genitalis and labialis. J Altern Complement Med 2007, 13(9):985-987.
66. Brisson M., Edmunds W.J., Law B., et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 2001, 127(2):305-314.
67. Helgason S., Petursson G., Gudmundsson S., et al. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ 2000, 321(7264):794-796.
68. Galil K., Choo P.W., Donahue J.G., et al. The sequelae of herpes zoster. Arch Intern Med 1997, 157(11):1209-1213.
69. Wood M.J., Kay R., Dworkin R.H., et al. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis 1996, 22(2):341-347.
70. Li Q., Chen N., Yang J., et al. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev 2009, (2). CD006866.
71. Dubinsky R.M., Kabbani H., El-Chami Z., et al. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004, 63(6):959-965.
72. Dworkin R.H., Corbin A.E., Young J.P., et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003, 60(8):1274-1283.
73. Watson C.P., Tyler K.L., Bickers D.R., et al. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 1993, 15(3):510-526.
74. Oxman M.N., Levin M.J., Johnson G.R., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005, 352(22):2271-2284.